Viewing Study NCT06121232


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2026-01-02 @ 12:27 PM
Study NCT ID: NCT06121232
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-17
First Post: 2023-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
Sponsor: M.D. Anderson Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-11-02
Start Date Type: ACTUAL
Primary Completion Date: 2026-04-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-04-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-10-25
First Submit QC Date: None
Study First Post Date: 2023-11-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-13
Last Update Post Date: 2025-11-17
Last Update Post Date Type: ESTIMATED